转自：北京日报客户端 数据来源 国家统计局官网 消费不仅关系经济发展，也关系民生改善。2025年前11个月，我国消费市场交出了一份稳健的成绩单： 社会消费品零售总额达45.6万亿元，同比增长4.0%，累计增速快于上年同期0.5个百分点。消费市场亮 点纷呈，文娱类和信息类服务消费需求较快释放，服务零售增长加快；消费新业态新模式蓬勃发展，线 上消费占比提升。 2025年年初以来，《提振消费专项行动方案》等政策密集出台，从增收减负、供给升级、环境优化等多 维度入手，构建起全方位的消费支撑体系。财政金融政策协同发力，形成"政府补贴+金融支持+商家优 惠"的联动效应；以旧换新、消费补贴等举措精准滴灌，激活大宗消费潜力。各项政策紧密配合、同向 发力，有效对冲了内外部环境变化带来的压力，稳住了消费基本盘。 但也要看到，近几个月消费增速有所放缓。特别是社会消费品零售总额增速已经连续6个月下降。一方 面受2024年基数较高的影响，另一方面也反映出内需不足仍是当前经济运行的突出矛盾。扩内需、促消 费，关键要找准要害、精准施策，既破解当前突出问题，又夯实长远发展基础。 收入稳则消费稳，收入增则消费旺。当前，部分居民消费信心不足，根 ...

提振消费，还要顺势而为。当前，我国正在从以商品消费为主转向商品消费和服务消费并重，一些领域 商品消费增速放缓，但文旅、养老、托育等服务消费需求旺盛。以文旅消费为例，长安十二时辰主题街 区以沉浸式体验让历史"可感知"，以科技手段让文化"可交互"，以业态融合实现"可消费"，有力促进了 西安甚至陕西的文旅经济增长。再以养老消费为例，适老化旅游、智慧康养服务备受青睐，社区嵌入式 养老设施需求旺盛。这些案例充分说明，服务消费潜力巨大，要持续扩大供给，更好适配群众需求。 扩大内需是2026年排在首位的重点任务，提振消费又是扩大内需的重中之重。我国拥有14亿多人口的超 大规模市场，消费升级趋势不可逆转。牢牢抓住提高居民收入这个核心，持续做强服务消费这个增长 点，不断完善政策支持体系，就一定能激活消费市场的无限潜力，让消费持续成为拉动经济增长的强劲 引擎。 消费不仅关系经济发展，也关系民生改善。2025年前11个月，我国消费市场交出了一份稳健的成绩单： 社会消费品零售总额达45.6万亿元，同比增长4.0%，累计增速快于上年同期0.5个百分点。消费市场亮 点纷呈，文娱类和信息类服务消费需求较快释放，服务零售增长加快；消费新业态 ...

国际医学回复：您好，感谢您对公司的关注。公司本次向特定对象发行股票是基于长远发展战略作出的 审慎决策，已制定募集资金使用可行性分析报告。根据公司2025年12月3日披露的《2025年度向特定对 象发行股票预案》，本次募集资金总额不超过100,753.93万元，将主要用于智慧康养项目、质子治疗中 心二期项目以及补充流动资金。其中智慧康养项目总投资约7.51亿元，拟投入募集资金约6.38亿元，旨 在把握"银发经济"发展机遇，盘活公司存量资产；质子治疗中心二期项目总投资9993.13万元，拟投入 募集资金9993.13万元，旨在填补西北地区质子治疗市场空白；补充流动资金2.7亿元，旨在优化公司资 本结构，提高持续经营能力。公司本次向特定对象发行股票是顺应国家政策，基于公司发展战略作出的 主动选择，旨在把握行业发展机遇，优化资本结构，盘活存量资产，满足未来业务发展的资金需求，提 高持续经营能力。公司将持续规范运作，切实维护全体股东特别是中小股东的合法权益。谢谢！ 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 投资者提问：定增没有具体事实计 ...

证券日报网讯 12月25日，国际医学（000516）在互动平台回答投资者提问时表示，公司计划以全资子 公司西安国际医学中心有限公司作为募投项目实施主体，项目实施地点为西安市高新区。智慧康养项目 拟打造集医养护理、康复专科治疗、智能养老照料、健康管理等功能为一体的医疗、康复、养老、护理 全链条健康服务基地。公司下辖的西安国际中心医院目前仍有部分床位空余。为尽快提升该部分床位的 利用率，公司拟将这些床位改造为康养床位，盘活此部分存量资产。公司将根据项目的进展情况，按照 相关规定和要求及时履行信息披露义务，敬请关注公司后续公告。 ...

Core Viewpoint - International Medicine (000516.SZ) plans to raise up to 1.008 billion yuan through a private placement, focusing on three main areas: smart healthcare projects, proton therapy center phase II, and working capital supplementation [2][4] Group 1: Fundraising and Investment Focus - The fundraising will allocate 638 million yuan to smart healthcare projects, nearly 100 million yuan to the proton therapy center phase II, and 270 million yuan for working capital [2] - The smart healthcare project aims to utilize idle assets to "activate stock assets," responding to both policy demands and the need for asset revitalization [2][5] - The company intends to use 270 million yuan from the fundraising to meet operational funding needs and optimize its capital structure [2][5] Group 2: Financial Challenges - As of September 30, 2025, the company's debt-to-asset ratio reached 68.80%, significantly higher than the industry average, with a sharp decline in cash reserves from 1.52 billion yuan at the end of 2021 to 331 million yuan [4][7] - The company has substantial short-term borrowings of 995 million yuan and non-current liabilities due within a year totaling 905 million yuan, leading to a total of nearly 1.9 billion yuan in rigid debt due within a year [4] - The company has faced significant losses over the past four years, with cumulative losses reaching 2.621 billion yuan [7] Group 3: Market Opportunities and Strategic Adjustments - The company views the fundraising as a strategic adjustment to address market changes, financial pressures, and idle assets [3] - The smart healthcare project and proton therapy center phase II are seen as key initiatives to capitalize on the "silver economy" and high-end medical development opportunities [4][6] - The proton therapy center phase II aims to fill a market gap in the northwest region, where no proton therapy centers are currently operational [6] Group 4: Operational Efficiency and Cost Management - The company is attempting to improve operational efficiency through clinical pathway management and cost structure optimization [8][9] - As of the third quarter of 2025, the company reported a management expense ratio of 10.99%, a decrease from previous periods, indicating initial success in cost control [8] - The company plans to continue enhancing service quality and patient experience while exploring various specialized medical fields to build competitive advantages [9]

Group 1 - International Medical aims to create a dual-driven development model of "comprehensive medical care + specialized departments" and has announced a plan to raise up to 1.008 billion yuan through a targeted stock issuance [1] - The raised funds will primarily be invested in smart health care projects, the second phase of the proton therapy center, and to supplement working capital [1] Group 2 - The aging population in China is increasing, with approximately 220 million people aged 65 and above expected by the end of 2024, representing 15.6% of the total population [2] - China's total healthcare expenditure has grown from 3.54 trillion yuan in 2014 to 9.06 trillion yuan in 2023, with a compound annual growth rate of 11.01% [2] - The demand for healthcare services is expected to rise due to the increasing elderly population and enhanced health awareness among residents [2] Group 3 - The proportion of nursing beds in registered elderly care institutions in China was 65.7% by the end of 2024, indicating significant growth potential in the elderly care industry [3] - Policies have been introduced to promote the integration of medical and elderly care services, aiming to improve the care system for elderly individuals with disabilities or dementia [3] Group 4 - Proton therapy is highlighted as a cutting-edge cancer treatment method with high cure rates and low side effects, addressing the limitations of traditional radiation therapy [4] - There is a significant market demand for proton therapy in China, with only seven operational proton therapy centers as of 2024, despite approximately 4.8247 million new cancer cases reported in 2022 [4] Group 5 - The health policy framework aims to enhance cancer prevention and treatment systems by 2030, with a planned increase in the number of radiation therapy devices [5] - The proton therapy center's second phase project aligns with national industrial policy and aims to enhance the company's high-end diagnostic capabilities [6] Group 6 - The implementation of the fundraising projects will enable the company to extend its business from traditional diagnostics to high-end radiation therapy, creating a synergistic business model of "comprehensive diagnosis + precise radiation therapy" [6] - The projects will leverage existing medical resources to strengthen the company's core competitiveness in cancer treatment [6]

Core Viewpoint - The company, International Medicine, plans to raise up to 1.008 billion yuan through a private placement of shares, with the funds allocated for smart healthcare projects, the second phase of the proton therapy center, and to supplement working capital [1][2]. Group 1: Fundraising and Project Allocation - The fundraising will support the transition of the company's business from traditional medical services to high-end radiation therapy, establishing a synergistic business model of "comprehensive diagnosis + precise radiation therapy" [1]. - A significant portion of the raised funds will be directed towards the smart healthcare project, utilizing idle spaces to enhance asset utilization and generate high-value healthcare services [1]. - The second phase of the proton therapy center aims to establish the first operational proton therapy project in Northwest China [2]. Group 2: Financial Performance and Debt Management - The company has experienced substantial losses over recent years, with cumulative losses of 2.621 billion yuan from 2021 to 2024 [3]. - In the first three quarters of 2025, the company reported a revenue of 2.995 billion yuan, a year-on-year decline of 16.94%, and a net loss of 294 million yuan, representing a 38.45% increase in losses compared to the previous year [3]. - The company has a high debt ratio of 68.80%, and the fundraising is expected to help reduce this ratio and optimize the capital structure [1].

五月末，山东更开放、更具发展活力。 2025山东国际友城合作交流周5月27日在济南启动。活动由山东省政府主办，主题为"携手同行 合作发 展"。 汤加外交大臣兼国防大臣图普托阿王储出席并致辞，泰国前副总理、泰中友好协会会长塔帕朗西出席， 省委书记林武致辞，省委副书记、省长周乃翔主持，省政协主席葛慧君，省委副书记、政法委书记王宇 燕出席。 5月27日至28日，青海省委书记吴晓军，省委副书记、省长罗东川率青海省党政代表团来我省考察。山 东省委书记林武，省委副书记、省长周乃翔，省委副书记、政法委书记王宇燕出席。 27日，两省召开座谈会，对接对口支援工作。林武代表山东省委、省政府对青海省党政代表团的到来表 示欢迎，对青海省给予山东工作的支持帮助表示感谢。他说，当前，山东正深入贯彻落实习近平总书记 视察山东重要讲话精神，锚定"走在前、挑大梁"，统筹推进稳增长、提质效、推改革、防风险、惠民 生，奋力谱写中国式现代化山东篇章。近年来，青海省推进中国式现代化青海实践迈出坚实步伐，许多 好经验好做法值得山东认真学习借鉴。我们愿与青海一道，坚决贯彻落实习近平总书记重要指示要求和 党中央决策部署，落实好黄河重大国家战略，立足青海所需 ...